Verastem, Inc. Deferred Tax Liabilities, Gross
Verastem, Inc. (VSTM) had Deferred Tax Liabilities, Gross of $119.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-04
- 2025-12-31: Deferred Tax Liabilities, Gross $119.00K.
- 2024-12-31: Deferred Tax Liabilities, Gross $362.00K.
- 2023-12-31: Deferred Tax Liabilities, Gross $248.00K.
- 2022-12-31: Deferred Tax Liabilities, Gross $458.00K.
| Period end | Deferred Tax Liabilities, Gross | Deferred Tax Liabilities, Gross as first filed |
|---|---|---|
| 2025-12-31 | $119.00K 10-K · filed 2026-03-04 | |
| 2024-12-31 | $362.00K 10-K · filed 2026-03-04 | |
| 2023-12-31 | $248.00K 10-K · filed 2025-03-20 | |
| 2022-12-31 | $458.00K 10-K · filed 2024-03-14 | |
| 2021-12-31 | $676.00K 10-K · filed 2023-03-14 | |
| 2020-12-31 | $2.99M 10-K · filed 2022-03-28 | $2.25M 10-K · filed 2021-03-18 |
| 2019-12-31 | $3.70M 10-K · filed 2021-03-18 | |
| 2018-12-31 | $13.62M 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |